81 related articles for article (PubMed ID: 11709793)
1. Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis.
Borjesson DL; Simon SI; Tablin F; Barthold SW
J Infect Dis; 2001 Dec; 184(11):1475-9. PubMed ID: 11709793
[TBL] [Abstract][Full Text] [Related]
2. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system.
Bunnell JE; Trigiani ER; Srinivas SR; Dumler JS
J Infect Dis; 1999 Aug; 180(2):546-50. PubMed ID: 10395880
[TBL] [Abstract][Full Text] [Related]
3. The mouse as a model for investigation of human granulocytic ehrlichiosis: current knowledge and future directions.
Borjesson DL; Barthold SW
Comp Med; 2002 Oct; 52(5):403-13. PubMed ID: 12405632
[TBL] [Abstract][Full Text] [Related]
4. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model.
Martin ME; Bunnell JE; Dumler JS
J Infect Dis; 2000 Jan; 181(1):374-8. PubMed ID: 10608792
[TBL] [Abstract][Full Text] [Related]
5. C3H mice have larger spleens, lower platelet counts, and shorter platelet lifespans than C57BL mice: an animal model for the study of hypersplenism.
Manning KL; McDonald TP
Exp Hematol; 1997 Sep; 25(10):1019-24. PubMed ID: 9293898
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopenia in association with splenomegaly during granulocyte-colony-stimulating factor treatment in mice is not caused by hypersplenism and is resolved spontaneously.
Takamatsu Y; Jimi S; Sato T; Hara S; Suzumiya J; Tamura K
Transfusion; 2007 Jan; 47(1):41-9. PubMed ID: 17207228
[TBL] [Abstract][Full Text] [Related]
7. Balancing protective immunity and immunopathology: a unifying model of monocytotropic ehrlichiosis.
Ismail N; Walker DH
Ann N Y Acad Sci; 2005 Dec; 1063():383-94. PubMed ID: 16481546
[TBL] [Abstract][Full Text] [Related]
8. Infection of mice with the agent of human granulocytic ehrlichiosis after different routes of inoculation.
Hodzic E; Feng S; Fish D; Leutenegger CM; Freet KJ; Barthold SW
J Infect Dis; 2001 Jun; 183(12):1781-6. PubMed ID: 11372031
[TBL] [Abstract][Full Text] [Related]
9. Rapid recovery of platelet count following administration of liposome-encapsulated clodronate in a mouse model of immune thrombocytopenia.
Alves-Rosa F; Stanganelli C; Cabrera J; Cymberknop D; Rubel C; Vanzulli S; van Rooijen N; Palermo M; Isturiz MA
Br J Haematol; 2002 Feb; 116(2):357-66. PubMed ID: 11841439
[TBL] [Abstract][Full Text] [Related]
10. Granulocytic ehrlichiosis in the laboratory mouse.
Hodzic E; Ijdo JW; Feng S; Katavolos P; Sun W; Maretzki CH; Fish D; Fikrig E; Telford SR; Barthold SW
J Infect Dis; 1998 Mar; 177(3):737-45. PubMed ID: 9498456
[TBL] [Abstract][Full Text] [Related]
11. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia.
Akkoyunlu M; Fikrig E
Infect Immun; 2000 Apr; 68(4):1827-33. PubMed ID: 10722570
[TBL] [Abstract][Full Text] [Related]
12. Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis.
Lotric-Furlan S; Petrovec M; Avsic-Zupanc T; Strle F
Scand J Infect Dis; 2004; 36(11-12):817-22. PubMed ID: 15764167
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of human granulocytic ehrlichiosis infection in Belgium.
Guillaume B; Heyman P; Lafontaine S; Vandenvelde C; Delmée M; Bigaignon G
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):397-400. PubMed ID: 12072927
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility and resistance to monocytic ehrlichiosis in the mouse.
Winslow GM; Bitsaktsis C; Yager E
Ann N Y Acad Sci; 2005 Dec; 1063():395-402. PubMed ID: 16481547
[TBL] [Abstract][Full Text] [Related]
15. [Human granulocytic ehrlichiosis co-incident with Lyme borreliosis in pregnant woman--a case study].
Brzostek T
Przegl Epidemiol; 2004; 58(2):289-94. PubMed ID: 15517809
[TBL] [Abstract][Full Text] [Related]
16. Role of the spleen and lymphocytes in regulation of the circulating platelet number in mice.
Bessler H; Mandel EM; Djaldetti M
J Lab Clin Med; 1978 May; 91(5):760-8. PubMed ID: 641398
[TBL] [Abstract][Full Text] [Related]
17. Immunization against the agent of human granulocytic ehrlichiosis in a murine model.
Sun W; IJdo JW; Telford SR; Hodzic E; Zhang Y; Barthold SW; Fikrig E
J Clin Invest; 1997 Dec; 100(12):3014-8. PubMed ID: 9399947
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis.
Akkoyunlu M; Malawista SE; Anguita J; Fikrig E
Infect Immun; 2001 Sep; 69(9):5577-88. PubMed ID: 11500432
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the degree of thrombocytopenia and infection with Ehrlichia canis in an endemic area.
Bulla C; Kiomi Takahira R; Pessoa Araújo J; AparecidaTrinca L; Souza Lopes R; Wiedmeyer CE
Vet Res; 2004; 35(1):141-6. PubMed ID: 15099511
[TBL] [Abstract][Full Text] [Related]
20. Experimental infection of C3H/HeJ mice with the NY18 isolate of Anaplasma phagocytophilum.
Blas-Machado U; de la Fuente J; Blouin EF; Almazán C; Kocan KM; Mysore JV
Vet Pathol; 2007 Jan; 44(1):64-73. PubMed ID: 17197625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
